Kaposi's sarcoma herpesvirus-induced endothelial cell reprogramming supports viral persistence and contributes to Kaposi's sarcoma tumorigenesis

Chang, 1994, Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma, Science, 266, 1865, 10.1126/science.7997879 Russo, 1996, Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8), Proc Natl Acad Sci U S A, 93, 14862, 10.1073/pnas.93.25.14862 Cesarman, 1995, Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas, N Engl J Med, 332, 1186, 10.1056/NEJM199505043321802 Soulier, 1995, Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease, Blood, 86, 1276, 10.1182/blood.V86.4.1276.bloodjournal8641276 Wong, 2017, Modulation of oncogenic signaling networks by Kaposi's sarcoma-associated herpesvirus, Biol Chem Dittmer, 2016, Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy, J Clin Invest, 126, 3165, 10.1172/JCI84418 Abere, 2016, KSHV non-structural membrane proteins involved in the activation of intracellular signaling pathways and the pathogenesis of Kaposi's sarcoma, Curr Opin Virol, 20, 11, 10.1016/j.coviro.2016.07.008 Gramolelli, 2015, The role of Kaposi sarcoma-associated herpesvirus in the pathogenesis of Kaposi sarcoma, J Pathol, 235, 368, 10.1002/path.4441 Schulz, 2015, Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis, Curr Opin Virol, 14, 116, 10.1016/j.coviro.2015.08.016 Mendez, 2000, Kaposi's sarcoma and transplantation, Herpes, 7, 18 Wood, 2008, The malignant potential of HIV-associated Kaposi sarcoma, Cancer Cell Int, 8, 14, 10.1186/1475-2867-8-14 Gessain, 2005, Spindle cells and their role in Kaposi's sarcoma, Int J Biochem Cell Biol, 37, 2457, 10.1016/j.biocel.2005.01.018 Wang, 2004, Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma, Nat Genet, 36, 687, 10.1038/ng1384 Cheng, 2011, KSHV-initiated notch activation leads to membrane-type-1 matrix metalloproteinase-dependent lymphatic endothelial-to-mesenchymal transition, Cell Host Microbe, 10, 577, 10.1016/j.chom.2011.10.011 Weich, 1991, AIDS-associated Kaposi's sarcoma-derived cells in long-term culture express and synthesize smooth muscle alpha-actin, Am J Pathol, 139, 1251 Pyakurel, 2006, Lymphatic and vascular origin of Kaposi's sarcoma spindle cells during tumor development, Int J Cancer, 119, 1262, 10.1002/ijc.21969 Simonart, 2002, Expression of the fibroblast/macrophage marker 1B10 by spindle cells in Kaposi's sarcoma lesions and by Kaposi's sarcoma-derived tumor cells, J Cutan Pathol, 29, 72, 10.1034/j.1600-0560.2002.290202.x Sturzl, 1995, Identification of interleukin-1 and platelet-derived growth factor-B as major mitogens for the spindle cells of Kaposi's sarcoma: a combined in vitro and in vivo analysis, Oncogene, 10, 2007 Cancian, 2013, Cellular origin of Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus-induced cell reprogramming, Trends Cell Biol, 23, 421, 10.1016/j.tcb.2013.04.001 Ojala, 2014, Manipulation of endothelial cells by KSHV: implications for angiogenesis and aberrant vascular differentiation, Semin Cancer Biol, 26, 69, 10.1016/j.semcancer.2014.01.008 Wang, 2008, Kaposi's sarcoma-associated herpesvirus confers a survival advantage to endothelial cells, Cancer Res, 68, 4640, 10.1158/0008-5472.CAN-07-5988 Gasperini, 2012, Kaposi sarcoma herpesvirus promotes endothelial-to-mesenchymal transition through Notch-dependent signaling, Cancer Res, 72, 1157, 10.1158/0008-5472.CAN-11-3067 Cheng, 2012, Instigation of Notch signaling in the pathogenesis of Kaposi's sarcoma-associated herpesvirus and other human tumor viruses, Future Microbiol, 7, 1191, 10.2217/fmb.12.95 Radu, 2013, Kaposi sarcoma, Arch Pathol Lab Med, 137, 289, 10.5858/arpa.2012-0101-RS Pantanowitz, 2008, Kaposi sarcoma in unusual locations, BMC Cancer, 8, 190, 10.1186/1471-2407-8-190 Dorfman, 1988, Kaposi's sarcoma: evidence supporting its origin from the lymphatic system, Lymphology, 21, 45 Dupin, 1999, Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma, Proc Natl Acad Sci U S A, 96, 4546, 10.1073/pnas.96.8.4546 Benevenuto de Andrade, 2014, Expression of PROX-1 in oral Kaposi's sarcoma spindle cells, J Oral Pathol Med, 43, 132, 10.1111/jop.12097 Della Bella, 2008, Peripheral blood endothelial progenitors as potential reservoirs of Kaposi's sarcoma-associated herpesvirus, PLoS ONE, 3, e1520, 10.1371/journal.pone.0001520 Calcaterra, 2017, Increased frequency and vasculogenic potential of endothelial colony-forming cells in patients with Kaposi's sarcoma, J Invest Dermatol, 10.1016/j.jid.2017.02.979 Browning, 1994, Identification and culture of Kaposi's sarcoma-like spindle cells from the peripheral blood of human immunodeficiency virus-1-infected individuals and normal controls, Blood, 84, 2711, 10.1182/blood.V84.8.2711.2711 Douglas, 2007, Kaposi's sarcoma: a model of both malignancy and chronic inflammation, Panminerva Med, 49, 119 Hong, 2002, Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate, Dev Dyn, 225, 351, 10.1002/dvdy.10163 Wigle, 2002, An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype, EMBO J, 21, 1505, 10.1093/emboj/21.7.1505 Wigle, 1999, Prox1 function is required for the development of the murine lymphatic system, Cell, 98, 769, 10.1016/S0092-8674(00)81511-1 Bixel, 2008, Master and commander: continued expression of Prox1 prevents the dedifferentiation of lymphatic endothelial cells, Genes Dev, 22, 3232, 10.1101/gad.1751908 Johnson, 2008, Lymphatic endothelial cell identity is reversible and its maintenance requires Prox1 activity, Genes Dev, 22, 3282, 10.1101/gad.1727208 Petrova, 2002, Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor, EMBO J, 21, 4593, 10.1093/emboj/cdf470 Hong, 2004, Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus, Nat Genet, 36, 683, 10.1038/ng1383 Carroll, 2004, Kaposi's sarcoma-associated herpesvirus infection of blood endothelial cells induces lymphatic differentiation, Virology, 328, 7, 10.1016/j.virol.2004.07.008 Emuss, 2009, KSHV manipulates Notch signaling by DLL4 and JAG1 to alter cell cycle genes in lymphatic endothelia, PLoS Pathog, 5, e1000616, 10.1371/journal.ppat.1000616 Hansen, 2010, KSHV-encoded miRNAs target MAF to induce endothelial cell reprogramming, Genes Dev, 24, 195, 10.1101/gad.553410 Mocroft, 1996, Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group, AIDS, 10, 1101 Spano, 2000, Factors predictive of disease progression and death in AIDS-related Kaposi's sarcoma, HIV Med, 1, 232, 10.1046/j.1468-1293.2000.00034.x Glesby, 1996, Use of antiherpes drugs and the risk of Kaposi's sarcoma: data from the Multicenter AIDS Cohort Study, J Infect Dis, 173, 1477, 10.1093/infdis/173.6.1477 Staskus, 1997, Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells, J Virol, 71, 715, 10.1128/JVI.71.1.715-719.1997 Cavallin, 2014, Molecular and cellular mechanisms of KSHV oncogenesis of Kaposi's sarcoma associated with HIV/AIDS, PLoS Pathog, 10, e1004154, 10.1371/journal.ppat.1004154 Mesri, 2013, Molecular studies and therapeutic targeting of Kaposi's sarcoma herpesvirus (KSHV/HHV-8) oncogenesis, Immunol Res, 57, 159, 10.1007/s12026-013-8458-z Glaunsinger, 2004, Lytic KSHV infection inhibits host gene expression by accelerating global mRNA turnover, Mol Cell, 13, 713, 10.1016/S1097-2765(04)00091-7 Glaunsinger, 2004, Highly selective escape from KSHV-mediated host mRNA shutoff and its implications for viral pathogenesis, J Exp Med, 200, 391, 10.1084/jem.20031881 Chandriani, 2007, Host transcript accumulation during lytic KSHV infection reveals several classes of host responses, PLoS ONE, 2, e811, 10.1371/journal.pone.0000811 Grundhoff, 2004, Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis, J Clin Invest, 113, 124, 10.1172/JCI200417803 Lagunoff, 2002, De novo infection and serial transmission of Kaposi's sarcoma-associated herpesvirus in cultured endothelial cells, J Virol, 76, 2440, 10.1128/jvi.76.5.2440-2448.2002 McAllister, 2007, Endothelial cell- and lymphocyte-based in vitro systems for understanding KSHV biology, Curr Top Microbiol Immunol, 312, 211 Sturzl, 2013, Kaposi's sarcoma-derived cell line SLK is not of endothelial origin, but is a contaminant from a known renal carcinoma cell line, Int J Cancer, 132, 1954, 10.1002/ijc.27849 Renne, 1998, Limited transmission of Kaposi's sarcoma-associated herpesvirus in cultured cells, J Virol, 72, 5182, 10.1128/JVI.72.6.5182-5188.1998 Drexler, 1998, Lymphoma cell lines: in vitro models for the study of HHV-8+ primary effusion lymphomas (body cavity-based lymphomas), Leukemia, 12, 1507, 10.1038/sj.leu.2401160 Mutlu, 2007, In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma, Cancer Cell, 11, 245, 10.1016/j.ccr.2007.01.015 Austgen, 2012, Multiple defects, including premature apoptosis, prevent Kaposi's sarcoma-associated herpesvirus replication in murine cells, J Virol, 86, 1877, 10.1128/JVI.06600-11 Chang, 2013, A unique herpesviral transcriptional program in KSHV-infected lymphatic endothelial cells leads to mTORC1 activation and rapamycin sensitivity, Cell Host Microbe, 13, 429, 10.1016/j.chom.2013.03.009 Yogev, 2013, Redefining KSHV latency, Cell Host Microbe, 13, 373, 10.1016/j.chom.2013.04.003 Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 Weitzman, 2004, Interactions of viruses with the cellular DNA repair machinery, DNA Repair (Amst), 3, 1165, 10.1016/j.dnarep.2004.03.018 Hollingworth, 2015, Modulation of DNA damage and repair pathways by human tumour viruses, Viruses, 7, 2542, 10.3390/v7052542 Koopal, 2007, Viral oncogene-induced DNA damage response is activated in Kaposi sarcoma tumorigenesis, PLoS Pathog, 3, 1348, 10.1371/journal.ppat.0030140 Singh, 2014, Kaposi's sarcoma-associated herpesvirus induces the ATM and H2AX DNA damage response early during de novo infection of primary endothelial cells, which play roles in latency establishment, J Virol, 88, 2821, 10.1128/JVI.03126-13 Jackson, 2014, A novel mechanism inducing genome instability in Kaposi's sarcoma-associated herpesvirus infected cells, PLoS Pathog, 10, e1004098, 10.1371/journal.ppat.1004098 Hollingworth, 2015, Activation of DNA damage response pathways during lytic replication of KSHV, Viruses, 7, 2908, 10.3390/v7062752 Balistreri, 2016, Oncogenic herpesvirus utilizes stress-induced cell cycle checkpoints for efficient lytic replication, PLoS Pathog, 12, e1005424, 10.1371/journal.ppat.1005424 Hosseinipour, 2014, Viral profiling identifies multiple subtypes of Kaposi's sarcoma, MBio, 5, 10.1128/mBio.01633-14